Heart Failure in Non-Caucasians, Women, and Older Adults

A White Paper on Special Populations from the Heart Failure Society of America Guideline Committee

Monica Colvin, Nancy K Sweitzer, Nancy M. Albert, Rajan Krishnamani, Michael W. Rich, Wendy Gattis Stough, Mary Norine Walsh, Cheryl A. Westlake Canary, Larry A. Allen, Mark R. Bonnell, Peter E. Carson, Michael C. Chan, Michael G. Dickinson, Daniel L. Dries, Gregory A. Ewald, James C. Fang, Adrian F. Hernandez, Ray E. Hershberger, Stuart D. Katz, Stephanie Moore & 5 others Jo E. Rodgers, Joseph G. Rogers, Amanda R. Vest, David J. Whellan, Michael M. Givertz

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The presentation, natural history, clinical outcomes, and response to therapy in patients with heart failure differ in some ways across populations. Women, older adults, and non-Caucasian racial or ethnic groups compose a substantial proportion of the overall heart failure population, but they have typically been underrepresented in clinical trials. As a result, uncertainty exists about the efficacy of some guideline-directed medical therapies and devices in specific populations, which may result in the under- or overtreatment of these patients. Even when guideline-based treatments are prescribed, socioeconomic, physical, or psychologic factors may affect non-Caucasian and older adult patient groups to a different extent and affect the application, effectiveness, and tolerability of these therapies. Individualized therapy based on tailored biology (genetics, proteomics, metabolomics), socioeconomic and cultural considerations, and individual goals and preferences may be the optimal approach for managing diverse patients. This comprehensive approach to personalized medicine is evolving, but in the interim, the scientific community should continue efforts focused on intensifying research in special populations, prescribing guideline-directed medical therapy unless contraindicated, and implementing evidence-based strategies including patient and family education and multidisciplinary team care in the management of patients.

Original languageEnglish (US)
Pages (from-to)674-693
Number of pages20
JournalJournal of Cardiac Failure
Volume21
Issue number8
DOIs
StatePublished - Aug 1 2015

Fingerprint

Heart Failure
Guidelines
Population
Therapeutics
Patient Care Management
Precision Medicine
Metabolomics
Patient Education
Natural History
Ethnic Groups
Proteomics
Uncertainty
Clinical Trials
Equipment and Supplies
Research

Keywords

  • African American
  • elderly
  • Heart failure
  • women

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Heart Failure in Non-Caucasians, Women, and Older Adults : A White Paper on Special Populations from the Heart Failure Society of America Guideline Committee. / Colvin, Monica; Sweitzer, Nancy K; Albert, Nancy M.; Krishnamani, Rajan; Rich, Michael W.; Stough, Wendy Gattis; Walsh, Mary Norine; Westlake Canary, Cheryl A.; Allen, Larry A.; Bonnell, Mark R.; Carson, Peter E.; Chan, Michael C.; Dickinson, Michael G.; Dries, Daniel L.; Ewald, Gregory A.; Fang, James C.; Hernandez, Adrian F.; Hershberger, Ray E.; Katz, Stuart D.; Moore, Stephanie; Rodgers, Jo E.; Rogers, Joseph G.; Vest, Amanda R.; Whellan, David J.; Givertz, Michael M.

In: Journal of Cardiac Failure, Vol. 21, No. 8, 01.08.2015, p. 674-693.

Research output: Contribution to journalArticle

Colvin, M, Sweitzer, NK, Albert, NM, Krishnamani, R, Rich, MW, Stough, WG, Walsh, MN, Westlake Canary, CA, Allen, LA, Bonnell, MR, Carson, PE, Chan, MC, Dickinson, MG, Dries, DL, Ewald, GA, Fang, JC, Hernandez, AF, Hershberger, RE, Katz, SD, Moore, S, Rodgers, JE, Rogers, JG, Vest, AR, Whellan, DJ & Givertz, MM 2015, 'Heart Failure in Non-Caucasians, Women, and Older Adults: A White Paper on Special Populations from the Heart Failure Society of America Guideline Committee', Journal of Cardiac Failure, vol. 21, no. 8, pp. 674-693. https://doi.org/10.1016/j.cardfail.2015.05.013
Colvin, Monica ; Sweitzer, Nancy K ; Albert, Nancy M. ; Krishnamani, Rajan ; Rich, Michael W. ; Stough, Wendy Gattis ; Walsh, Mary Norine ; Westlake Canary, Cheryl A. ; Allen, Larry A. ; Bonnell, Mark R. ; Carson, Peter E. ; Chan, Michael C. ; Dickinson, Michael G. ; Dries, Daniel L. ; Ewald, Gregory A. ; Fang, James C. ; Hernandez, Adrian F. ; Hershberger, Ray E. ; Katz, Stuart D. ; Moore, Stephanie ; Rodgers, Jo E. ; Rogers, Joseph G. ; Vest, Amanda R. ; Whellan, David J. ; Givertz, Michael M. / Heart Failure in Non-Caucasians, Women, and Older Adults : A White Paper on Special Populations from the Heart Failure Society of America Guideline Committee. In: Journal of Cardiac Failure. 2015 ; Vol. 21, No. 8. pp. 674-693.
@article{0c7ba386f58f46a88525d17827bc3fea,
title = "Heart Failure in Non-Caucasians, Women, and Older Adults: A White Paper on Special Populations from the Heart Failure Society of America Guideline Committee",
abstract = "The presentation, natural history, clinical outcomes, and response to therapy in patients with heart failure differ in some ways across populations. Women, older adults, and non-Caucasian racial or ethnic groups compose a substantial proportion of the overall heart failure population, but they have typically been underrepresented in clinical trials. As a result, uncertainty exists about the efficacy of some guideline-directed medical therapies and devices in specific populations, which may result in the under- or overtreatment of these patients. Even when guideline-based treatments are prescribed, socioeconomic, physical, or psychologic factors may affect non-Caucasian and older adult patient groups to a different extent and affect the application, effectiveness, and tolerability of these therapies. Individualized therapy based on tailored biology (genetics, proteomics, metabolomics), socioeconomic and cultural considerations, and individual goals and preferences may be the optimal approach for managing diverse patients. This comprehensive approach to personalized medicine is evolving, but in the interim, the scientific community should continue efforts focused on intensifying research in special populations, prescribing guideline-directed medical therapy unless contraindicated, and implementing evidence-based strategies including patient and family education and multidisciplinary team care in the management of patients.",
keywords = "African American, elderly, Heart failure, women",
author = "Monica Colvin and Sweitzer, {Nancy K} and Albert, {Nancy M.} and Rajan Krishnamani and Rich, {Michael W.} and Stough, {Wendy Gattis} and Walsh, {Mary Norine} and {Westlake Canary}, {Cheryl A.} and Allen, {Larry A.} and Bonnell, {Mark R.} and Carson, {Peter E.} and Chan, {Michael C.} and Dickinson, {Michael G.} and Dries, {Daniel L.} and Ewald, {Gregory A.} and Fang, {James C.} and Hernandez, {Adrian F.} and Hershberger, {Ray E.} and Katz, {Stuart D.} and Stephanie Moore and Rodgers, {Jo E.} and Rogers, {Joseph G.} and Vest, {Amanda R.} and Whellan, {David J.} and Givertz, {Michael M.}",
year = "2015",
month = "8",
day = "1",
doi = "10.1016/j.cardfail.2015.05.013",
language = "English (US)",
volume = "21",
pages = "674--693",
journal = "Journal of Cardiac Failure",
issn = "1071-9164",
publisher = "Churchill Livingstone",
number = "8",

}

TY - JOUR

T1 - Heart Failure in Non-Caucasians, Women, and Older Adults

T2 - A White Paper on Special Populations from the Heart Failure Society of America Guideline Committee

AU - Colvin, Monica

AU - Sweitzer, Nancy K

AU - Albert, Nancy M.

AU - Krishnamani, Rajan

AU - Rich, Michael W.

AU - Stough, Wendy Gattis

AU - Walsh, Mary Norine

AU - Westlake Canary, Cheryl A.

AU - Allen, Larry A.

AU - Bonnell, Mark R.

AU - Carson, Peter E.

AU - Chan, Michael C.

AU - Dickinson, Michael G.

AU - Dries, Daniel L.

AU - Ewald, Gregory A.

AU - Fang, James C.

AU - Hernandez, Adrian F.

AU - Hershberger, Ray E.

AU - Katz, Stuart D.

AU - Moore, Stephanie

AU - Rodgers, Jo E.

AU - Rogers, Joseph G.

AU - Vest, Amanda R.

AU - Whellan, David J.

AU - Givertz, Michael M.

PY - 2015/8/1

Y1 - 2015/8/1

N2 - The presentation, natural history, clinical outcomes, and response to therapy in patients with heart failure differ in some ways across populations. Women, older adults, and non-Caucasian racial or ethnic groups compose a substantial proportion of the overall heart failure population, but they have typically been underrepresented in clinical trials. As a result, uncertainty exists about the efficacy of some guideline-directed medical therapies and devices in specific populations, which may result in the under- or overtreatment of these patients. Even when guideline-based treatments are prescribed, socioeconomic, physical, or psychologic factors may affect non-Caucasian and older adult patient groups to a different extent and affect the application, effectiveness, and tolerability of these therapies. Individualized therapy based on tailored biology (genetics, proteomics, metabolomics), socioeconomic and cultural considerations, and individual goals and preferences may be the optimal approach for managing diverse patients. This comprehensive approach to personalized medicine is evolving, but in the interim, the scientific community should continue efforts focused on intensifying research in special populations, prescribing guideline-directed medical therapy unless contraindicated, and implementing evidence-based strategies including patient and family education and multidisciplinary team care in the management of patients.

AB - The presentation, natural history, clinical outcomes, and response to therapy in patients with heart failure differ in some ways across populations. Women, older adults, and non-Caucasian racial or ethnic groups compose a substantial proportion of the overall heart failure population, but they have typically been underrepresented in clinical trials. As a result, uncertainty exists about the efficacy of some guideline-directed medical therapies and devices in specific populations, which may result in the under- or overtreatment of these patients. Even when guideline-based treatments are prescribed, socioeconomic, physical, or psychologic factors may affect non-Caucasian and older adult patient groups to a different extent and affect the application, effectiveness, and tolerability of these therapies. Individualized therapy based on tailored biology (genetics, proteomics, metabolomics), socioeconomic and cultural considerations, and individual goals and preferences may be the optimal approach for managing diverse patients. This comprehensive approach to personalized medicine is evolving, but in the interim, the scientific community should continue efforts focused on intensifying research in special populations, prescribing guideline-directed medical therapy unless contraindicated, and implementing evidence-based strategies including patient and family education and multidisciplinary team care in the management of patients.

KW - African American

KW - elderly

KW - Heart failure

KW - women

UR - http://www.scopus.com/inward/record.url?scp=84938293575&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938293575&partnerID=8YFLogxK

U2 - 10.1016/j.cardfail.2015.05.013

DO - 10.1016/j.cardfail.2015.05.013

M3 - Article

VL - 21

SP - 674

EP - 693

JO - Journal of Cardiac Failure

JF - Journal of Cardiac Failure

SN - 1071-9164

IS - 8

ER -